Loading: 100%
Epizyme, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 112 (as per Q2 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker EPZMno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1705101520
datesClosing price (adj.)
13.10.201717.50
11.10.201717.95
04.10.201718.85
27.09.201717.25
20.09.201718.70
13.09.201715.95
06.09.201717.55
30.08.201717.10
23.08.201715.75
16.08.201713.85
09.08.201713.15
02.08.201712.10
26.07.201712.30
19.07.201713.70
12.07.201714.75
05.07.201715.60
27.06.201714.30
20.06.201713.75
13.06.201711.15
06.06.201712.80
30.05.201715.05
23.05.201716.65
16.05.201716.15
09.05.201715.85
02.05.201717.55
25.04.201717.45
18.04.201714.90
11.04.201714.55
04.04.201716.00
28.03.201717.40
21.03.201716.60
14.03.201716.40
07.03.201715.20
28.02.201714.20
21.02.201712.30
14.02.201712.05
07.02.201712.20
31.01.201710.50
24.01.201710.20
17.01.201710.50
10.01.201712.00
03.01.201712.30
27.12.201611.75
19.12.201611.70
12.12.201611.50
05.12.201610.90
28.11.201611.30
21.11.201611.30
14.11.201611.75
07.11.201610.00
31.10.20169.05
24.10.20169.00
17.10.20168.85
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
17.50n/a
Market Capitalisation
in million USD
1,014n/a
Enterprise Value
in million USD
726n/a
Common Shares Outstanding
as per Jun 30, 2016
57,937,000n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
48,944,250n/a
Average Diluted Shares Outstanding
TTM
48,944,250n/a
Index Membership
n/a
Business Summary
Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 289n/a
Receivables 0n/a
Total Current Assets 297n/a
PP&E 4n/a
Total Assets 301n/a
Accounts Payable 4n/a
Current Debt 1n/a
Total Current Liabilities 16n/a
Long-Term Debt 0n/a
Total Liabilities 46n/a
Total Equity 255n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital 5n/a
Operating Cash Flow -79n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow -200n/a
Dividends Paid 0n/a
Financing Cash Flow 132n/a
Total Change in Cash -147n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 5.21n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 3.36n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.25n/a
Other Ratios
Current Ratio 1,835.3%n/a
Liabilities to Equity Ratio 17.9%n/a
Debt to Assets Ratio 0.3%n/a
Profit & Loss StatementP&L data quality: 36% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Revenue
7
45
68
41
3
Sales & Services Revenue
0
0
0
0
0
Financing Revenue
0
0
0
0
0
Other Revenue
0
0
0
0
0
Cost of revenue
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
Gross Profit
7
45
68
41
3
Other Operating Income
0
0
0
0
0
Operating Expenses
-28
-46
-72
-96
-135
Selling, General & Administrative
-5
-8
-14
-21
-24
Selling & Marketing
0
0
0
0
0
General & Administrative
0
0
0
0
0
Research & Development
-23
-38
-58
-76
-111
Depreciation & Amortization
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
Operating Income (Loss)
-21
-1
-3
-55
-133
Non-Operating Income (Loss)
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
Interest Expense
0
0
0
0
0
Interest Income
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
Pretax Income (Loss), Adjusted
-21
-1
-3
-55
-132
Abnormal Gains (Losses)
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
Sale of Business
0
0
0
0
0
Legal Settlement
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
Pretax Income (Loss)
-21
-1
-3
-55
-132
Income Tax (Expense) Benefit, net
0
0
0
0
0
Current Income Tax
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
Income (Loss) from Continuing Operations
-21
-1
-3
-55
-132
Net Extraordinary Gains (Losses)
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
Income (Loss) Including Minority Interest
-21
-1
-3
-55
-132
Minority Interest
0
0
0
0
0
Net Income
-21
-1
-3
-55
-132
Preferred Dividends
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Net Income Available to Common Shareholders
-21
-1
-3
-55
-132
Remarks
restated on Feb 28, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
98
124
190
208
Cash & Cash Equivalents
n/a
98
124
190
208
Short Term Investments
n/a
0
0
0
0
Accounts & Notes Receivable
n/a
2
34
2
0
Accounts Receivable, Net
n/a
2
34
2
0
Notes Receivable, Net
n/a
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
Inventories
n/a
0
0
0
0
Raw Materials
n/a
0
0
0
0
Work In Process
n/a
0
0
0
0
Finished Goods
n/a
0
0
0
0
Other Inventory
n/a
0
0
0
0
Other Short Term Assets
n/a
1
2
3
4
Prepaid Expenses
n/a
1
2
3
4
Derivative & Hedging Assets
n/a
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
Total Current Assets
n/a
101
160
195
213
Property, Plant & Equipment, Net
n/a
2
2
4
4
Property, Plant & Equipment
n/a
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
Long Term Investments
n/a
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
Other Long Term Assets
n/a
1
1
1
1
Intangible Assets
n/a
0
0
0
0
Goodwill
n/a
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
Miscellaneous Long Term Assets
n/a
1
1
1
1
Total Noncurrent Assets
n/a
3
3
4
5
Total Assets
n/a
104
163
199
218
Liabilities and owners' equity
Payables & Accruals
n/a
7 7295000
11 11330000
15 15343000
16 15988000
Accounts Payable
n/a
3 2967000
5 4698000
8 8300000
5 4653000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
4 4328000
7 6632000
7 7043000
11 11335000
Short Term Debt
n/a
0 0
0 0
0 0
1 561000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
28 28208000
23 23243000
2 1702000
2 1900000
Deferred Revenue
n/a
28 28208000
23 23243000
2 1702000
2 1900000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
36 35503000
35 34573000
17 17045000
18 18449000
Long Term Debt
n/a
0 0
0 0
0 0
1 730000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
43 42978000
24 24102000
22 21876000
29 29192000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
41 41237000
24 23629000
21 21449000
29 28809000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2 1741000
0 473000
0 427000
0 383000
Total Noncurrent Liabilities
n/a
43 42978000
24 24102000
22 21876000
30 29922000
Total Liabilities
n/a
78 78481000
59 58675000
39 38921000
48 48371000
Preferred Equity
n/a
76 76156000
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
1 1471000
160 160393000
271 271367000
413 412993000
Common Stock
n/a
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-53 -52597000
-56 -56080000
-111 -111085000
-243 -243461000
Other Equity
n/a
0 0
0 0
0 0
0 0
Equity Before Minority Interest
n/a
25 25030000
104 104313000
160 160282000
170 169532000
Minority Interest
n/a
0 0
0 0
0 0
0 0
Total Equity
n/a
25 25030000
104 104313000
160 160282000
170 169532000
Total Liabilities & Equity
n/a
104 103511000
163 162988000
199 199203000
218 217903000
Remarks restated on n/a restated on Feb 28, 2014 n/a restated on Mar 12, 2015 n/a restated on Mar 9, 2016 n/a restated on Aug 8, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-21
-1
-3
-55
-132
Net Income
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Depreciation & Amortization
0
1
1
1
1
Non-Cash Items
0
1
3
7
50
Stock-Based Compensation
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
Change in Working Capital
30
43
-54
12
8
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
Cash from Operating Activities
10
44
-54
-35
-73
Change in Fixed Assets & Intangibles
-1
-1
-1
-2
-40
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
Cash from Investing Activities
-1
-1
-1
-2
-40
Dividends Paid
0
0
0
0
0
Cash From (Repayment of) Debt
19
22
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
83
104
132
Increase in Capital Stock
0
0
83
104
132
Decrease in Capital Stock
0
0
0
0
0
Other Financing Activities
0
0
-3
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
Cash from Financing Activities
19
22
80
104
131
Net Cash Before Disc. Operations and FX
28
65
26
67
18
Change in Cash from Disc. Operations and Other
0
0
0
0
0
Net Cash Before FX
28
65
26
67
18
Effect of Foreign Exchange Rates
0
0
0
0
0
Net Changes in Cash
28
65
26
67
18
Remarks
restated on Feb 28, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
restated on Mar 9, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo